
ZHONGCHAO INC-CLASS A
ZCMDNASDAQTrading Snapshot
- Day Range
- $1.07 β $1.09
- 52-Week Range
- $0.80 β $967.20
- Volume
- $1.82B
- Avg Volume
- $1.45B
- Shares Outstanding
- 34,728
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $11M
- Last Q Revenue
- $6M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-169.29
- Dividend Yield
- 0.00%
Why Investors Own ZCMD
- βHigh-growth profile β revenue up -1.0% YoY with expanding US Equity exposure.
- βHealthy economics β 71% gross margin and 29% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ZHONGCHAO INC-CLASS A
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ZHONGCHAO INC-CLASS A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ZCMD price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ZHONGCHAO INC-CLASS A announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.